FLG: Can you introduce yourself and your work? I’m Guillermo del Angel and I’m the Senior Director for Data Science […]
FLG: Can you introduce yourself and your work? I’m Sandra Smieszek and I’m the Head of Genetics at Vanda Pharmaceuticals […]
The growing epidemic of “The Silent Liver Disease” Non-alcoholic fatty liver disease (NAFLD) is experiencing a meteoric rise globally. NAFLD […]
Last week, we asked the genomics community how they were shifting their focus to help fight the novel coronavirus. We […]
Many pharmaceutical companies are switching their focus to collecting, analysing and learning from large data sets. In fact, in early […]
With the cost of developing a drug doubling every 9 years, the pharma business model will soon become largely unsustainable. […]
